Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thruvision secures £1m+ contract with Asian government client

(Sharecast News) - Thruvision Group announced on Wednesday that it has secured a material contract worth over £1m from a new government customer in Asia, providing 20 of its highest-specification walk-through security systems. The AIM-traded firm said the contract, secured in partnership with a regional distributor, followed the successful deployment of multiple 'WalkTHRU' screening lanes at a major cultural event in the region and highlighted growing demand for its technology in high-profile government settings.

It said the deal was one of the 'material opportunities' referenced in previous announcements, adding that delivery was scheduled in the coming weeks.

Order intake for the first quarter of the 2026 financial year, which ended on 30 June, reached £2.3m, up 145% year-on-year.

Thruvision said that performance was in line with board expectations and reflected strong momentum, particularly in Asia.

The company also noted solid demand in the US, where it secured further repeat orders from retail distribution customers, as well as its first contract with a UK prison, building on existing success with a European prison service.

Thruvision reported an improved cash outlook, saying its resources were now expected to last until the end of 2025.

That, the board said, was an extension from its previous estimate of September, though the company cautioned that it remained dependent on continued conversion of its sales pipeline in line with expectations.

At 1025 BST, shares in Thruvision were up 107.78% at 1.87p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.